Adaptimmune Therapeutics
ADAP
#8446
Rank
HK$1.20 B
Marketcap
HK$4.70
Share price
0.82%
Change (1 day)
20.41%
Change (1 year)

Adaptimmune Therapeutics (ADAP) - Cash on Hand

Cash on Hand as of September 2024 : HK$1.44 Billion

According to Adaptimmune Therapeutics's latest financial reports the company has HK$1.44 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Adaptimmune Therapeutics - Cash on Hand chart (from 2014 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31HK$1.14 B-28.21%
2022-12-31HK$1.59 B-44.53%
2021-12-31HK$2.88 B0.96%
2020-12-31HK$2.85 B309.33%
2019-12-31HK$0.69 B-56.59%
2018-12-31HK$1.60 B-1.28%
2017-12-31HK$1.62 B15.63%
2016-12-31HK$1.40 B
2015-06-30HK$2.20 B454.59%
2014-06-30HK$0.39 B20577.81%
2013-06-30HK$1.92 M-91.81%
2012-06-30HK$23.45 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
HK$7.06 B 388.76%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$0.40 B-71.86%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$3.38 B 133.89%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
HK$9.24 B 539.02%๐Ÿ‡บ๐Ÿ‡ธ USA